IGC Pharma (IGC) Cash from Operations Growth (5y) (2015 - 2025)
IGC Pharma (IGC) Cash from Operations Growth (5y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
IGC Pharma |
29.33 Mn |
29.07 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
3.22% |
| Jun 30, 2025 |
18.81% |
| Mar 31, 2025 |
18.20% |
| Dec 31, 2024 |
10.08% |
| Sep 30, 2024 |
8.72% |
| Jun 30, 2024 |
9.41% |
| Mar 31, 2024 |
14.45% |
| Dec 31, 2023 |
-3.58% |
| Sep 30, 2023 |
-38.63% |
| Jun 30, 2023 |
-22.37% |
| Mar 31, 2023 |
-9.63% |
| Dec 31, 2022 |
-36.64% |
| Sep 30, 2022 |
-74.21% |
| Jun 30, 2022 |
-33.29% |
| Mar 31, 2022 |
0.47% |
| Dec 31, 2021 |
-70.73% |
| Sep 30, 2021 |
-21.22% |
| Jun 30, 2021 |
-61.90% |
| Mar 31, 2021 |
-72.99% |
| Dec 31, 2020 |
-253.63% |
